Perspective on the serious illness, palliative, and caregiving market: who buys, how policy moves, and what it takes to cross the Atlantic with your story intact.
On October 13 I joined Punto Health for a Tardeo in Barcelona. A few reflections on what they're building, why it's rare, and why I think US dementia and caregiving teams should be paying attention.
Luke C. ScuittoFounder · Seat 1A
{{ p.excerpt }}
The policy moves, market data, and ecosystem news worth your attention across US and European agetech, caregiving, and serious illness care. Each comes with a one line read on why it matters.
The need keeps growing. The money is getting pickier.
Over half of agetech venture money has gone to US companies, and Spain has raised under $7M in ten years. For European teams, that gap is the case for coming to the US with a clear buyer and real outcomes.
{{ pick.longTake }}
{{ eDek }}
Luke C. ScuittoFounder · 1A Consulting
{{ b.text }}
{{ b.text }}